AbCellera Biologics Inc.ABCLNASDAQ
Loading
Debt to Equity Over TimeFair Value
Percentile Rank71
3Y CAGR+23.4%
5Y CAGR+72.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+23.4%/yr
vs -31.1%/yr prior
5Y CAGR
+72.7%/yr
Recent deceleration
Acceleration
+54.6pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
15.4x
Strong expansion
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.13 | +102.7% |
| 2024 | 0.06 | -7.8% |
| 2023 | 0.07 | +0.7% |
| 2022 | 0.07 | +70.8% |
| 2021 | 0.04 | +378.6% |
| 2020 | 0.01 | -98.8% |
| 2019 | 0.67 | +126.7% |
| 2018 | 0.30 | - |